Oxford drug delivery spinout Evox Therapeutics collected funding from Bill and Melinda Gates Foundation in its bid to engineer exosome delivery vessels for a range of drugs.

Drawing on PSL research expertise, patient billing management platform Sancare anticipates strengthening its links with the university following investment from the PSL Innovation Fund.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Cambridge neural interface spinout Bios will use some of the seed capital to develop an interface between prosthetic objects and the human nervous system.

The patient engagement software producer has landed $28m from new and existing investors roughly a year after being picked for the Cedars-Sinai accelerator.

The healthcare data analytics platform developer has added an undisclosed sum from Providence St Joseph Health to a round that reached a $12m first close in August.

The acquisition of respiratory management system developer Propeller Health will provide exits for McKesson, Aptar Pharma, Hikma, GlaxoSmithKline, Walgreens and 3M.

Vascudyne will develop vascular medical devices offering enhanced performance on the back of a stem cell-grown tissue with similar biological and mechanical qualities to the native equivalent.

Salubris Pharmaceuticals invested $10m to lead a NantKwest-backed round as part of a Chinese licensing agreement for Viracta's herpes therapies.

The KCL immuno-oncology spinout’s second series A close included investment from UCL Technology Fund, Alsa Holding and Epidarex Capital.